| Bioactivity | BMS-684 is a selective DGKα inhibitor with an IC50 of 15 nM. BMS-684 inhibits DGKα kinase activity with >100-fold selectivity over the related DGK type I family members DGKβ and DGKγ. BMS-684 does not inhibit any of the other seven DGK isozymes[1]. |
| Target | IC50: 15 nM (DGKα) |
| Name | BMS-684 |
| CAS | 313552-29-3 |
| Formula | C27H26N4O3 |
| Molar Mass | 454.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Michael Wichroski, et al. DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunity. Sci Transl Med. 2023 Oct 25;15(719):eadh1892. |
BMS-684
CAS: 313552-29-3 F: C27H26N4O3 W: 454.52
BMS-684 is a selective DGKα inhibitor with an IC50 of 15 nM. BMS-684 inhibits DGKα kinase activity with >100-fold sele
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.